Georgios Paterakis
About
In The Last Decade
Georgios Paterakis
30 papers receiving 360 citations
Peers
Comparison fields: 5 of 52
- Immunology 101
- Genetics 96
- Pathology and Forensic Medicine 94
- Oncology 92
- Hematology 92
Countries citing papers authored by Georgios Paterakis
This map shows the geographic impact of Georgios Paterakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgios Paterakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgios Paterakis more than expected).
Fields of papers citing papers by Georgios Paterakis
This network shows the impact of papers produced by Georgios Paterakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgios Paterakis. The network helps show where Georgios Paterakis may publish in the future.
Co-authorship network of co-authors of Georgios Paterakis
This figure shows the co-authorship network connecting the top 25 collaborators of Georgios Paterakis. A scholar is included among the top collaborators of Georgios Paterakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgios Paterakis. Georgios Paterakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 20 | |
| 6 | 7 | |
| 7 | 10 | |
| 8 | 53 | |
| 9 | 27 | |
| 10 | 13 | |
| 11 | 19 | |
| 12 | 9 | |
| 13 | 23 | |
| 14 | 2 | |
| 15 | 60 | |
| 16 | 8 | |
| 17 | 18 | |
| 18 | 6 | |
| 19 | Automated reticulocyte counting for monitoring patients on chemotherapy for acute leukaemias and malignant lymphomas. | 7 |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.